Episode
Advances in the Treatment of Urothelial Cancer
- Published
- Jan 31, 2025
- Duration seconds
- 132
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/nursing-excellence-in-cancer-care-cancer-nurses-society-of-australia-podcast-6586861/episodes/advances-in-the-treatment-of-urothelial-cancer/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/nursing-excellence-in-cancer-care-cancer-nurses-society-of-australia-podcast-6586861/advances-in-the-treatment-of-urothelial-cancer.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Evolving new treatments for patients with urothelial carcinoma now include antibody drug conjugates. In this podcast we explore how these work, where they fit into the available treatment options and the patient management strategies particularly for the latest treatments available to Australian patients. Helen Anderson, Genitourinary Cancer Nurse Navigator at the Gold Coast University Hospital is joined by Alex Mitchell, Cancer Care Co Ordinator from the Mater Hospital, Brisbane.